. 2019 Feb 14;13(2):e0007133. doi: 10.1371/journal.pntd.0007133

Table 1. Oligonucleotides used in this work.

Oligo No.	Sequence^a^,^b	Purposed^c	Orientation
RBF919	ccgCTCGAGCCATGGCCACCATGGAGGACGCCAAGAACATCAA	PpyRE9h	Forward
RBF920	aaggaaaaaaGCGGCCGCTCAGATCTTGCCGCCCTTCTTGG	PpyRE9h	Reverse
RBF 630	CTTGTTTCAAGGACTTAGCCATG	5′integration	Forward
RBF 637	TATTCGTTGTCAGATGGCGCAC	5′integration	Reverse
RBF 644	CATGTGCAGCTCCTCCCTTTC	3′integration	Forward
RBF 645	CCTTGTTACGACTTTTGCTTC	3′integration	Reverse

^aUnderlined sequence indicates restriction site.

^bBold sequence indicates optimized translation initiation sequence.

^cOrientation of primers: F, forward; R, reverse